Seven Mile Advisory’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Seven Mile Advisory's LLY Position: Q3 2026 in Review
Seven Mile Advisory reduced its Eli Lilly (LLY) stake by 7.3% in Q3 2026, selling an estimated $93.2K and leaving 1,006 shares worth $1.16M. The position accounts for 0.78% of the portfolio, ranked #22.
Seven Mile Advisory first reported a position in LLY in Q2 2023 and has held it in 14 quarters since. The position peaked at $1.94M in Q4 2025. 1,741 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Seven Mile Advisory held 1,006 shares of Eli Lilly worth $1.16M as of Q3 2026.
- Seven Mile Advisory sold 79 Eli Lilly shares in Q3 2026, an estimated $93.2K.
- Eli Lilly made up 0.78% of Seven Mile Advisory's portfolio in Q3 2026, its #22 holding.
- Seven Mile Advisory first reported a position in Eli Lilly in Q2 2023 and has held it in 14 quarters since.
- Seven Mile Advisory's Eli Lilly position peaked at $1.94M in Q4 2025.
- 1,741 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Seven Mile Advisory's 13F filing for Q3 2026, filed 22 Oct 2026.